Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Tarivid IV*


Contraindicated
Risk of damage to joint cartilage of the fetus

Contraindicated
Risk of arthropathy
Tarivid IV* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Aventis Deutschland GmbH
Origin Germany
Manufacturer Sanofi Aventis Deutschland GmbH
Origin Germany
ATC J01MA01

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 01/08/2014


Tarivid IV*  MoH 2891 :
Form Solution for infusion
Packaging Bottle
Package Size 5x100ml
Strength 200mg
NSSF
Quarantine
Reg. Number 27390
Submission date 01/01/1988
Registration Year 1988
Archived Date 2017





Price Comparison

Country: Switzerland
Package Size: 5
Public Price: 122.15 CHF ( 2,083,909.54 LBP )
Pack size unit used: 5
Cost/Unit: 24,43 CHF ( 409,446.00 LBP )
Exfactory Price: 92.13 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: KSA
Package Size: 100ml
Public Price: 409.8 SAR ( 1,651,649.72 LBP )
Pack size unit used: 5
Cost/Unit: 81,96 SAR ( 326,460.78 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: UK
Package Size: 1x100ml
Public Price: 16.16 GBP ( 325,636.44 LBP )
Pack size unit used: 1
Cost/Unit: 16,16 GBP ( 322,412.32 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Spain
Package Size: 1x100 ml
Public Price: 12.3 EUR ( 226,074.62 LBP )
Pack size unit used: 1
Cost/Unit: 12,3 EUR ( 220,560.60 LBP )
Medica Comments: SURNOX=Tarivid
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info